Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3380-3383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Side Effects of Beta-Blocker Treatment for Hypertension

By  

Scandinavian Journal of Primary Health Care, Vol. 18, Iss. 2, 2000-10 ,pp. : 127-128

Informa Healthcare

Access to resources Recommend Favorite

The role of ββ-blockers in the management of hypertension: An Asian perspective

By Tomlinson B.   Dalal J.J.   Huang J.   Low L.P.   Park C.G.   Rahman A.R.   Reyes E.B.   Soenarta A.A.   Heagerty A.   Follath F.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1021-1033

Informa Healthcare

Access to resources Recommend Favorite

Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database

By Lafuma A.   Berdeaux G.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

AchievemenT of target resting HEart rate on beta-blockers in patients with stable angiNA and hypertension (ATHENA) in routine clinical practice in Russia

By Kobalava Zhanna   Khomitskaya Yunona   Kiyakbaev Gayrat    

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 805-811

Informa Healthcare

Access to resources Recommend Favorite